•  
  •  
 

Abstract

INTRODUCTION: Medication adherence is crucial for managing respiratory diseases. Understanding the factors influencing adherence among patients with respiratory illnesses is essential for improving outcomes and optimizing treatment.

OBJECTIVE: This study explored the multifaceted factors influencing medication adherence among patients with respiratory illnesses, focusing on patient characteristics, clinical factors, beliefs about medications, and reasons for irregular medication use.

METHODOLOGY: A cross-sectional design assessed medication adherence and beliefs in chronic obstructive pulmonary disease (COPD) patients through questionnaires. Patient demographics and clinical characteristics were analyzed to understand their impact on adherence.

STATISTICAL ANALYSIS USED: Medication adherence was measured using the Adherence to Refills and Medications Scale (ARMS). Descriptive statistics summarized patient demographics and clinical characteristics. Correlations between various factors and adherence levels were determined.

RESULTS: The study identified a middle-aged population with an average age of 48.5 years and a high smoking prevalence, aligning with COPD risk factors. Medication adherence scores indicated moderate levels (average ARMS score: 62.7), with significant individual variation. Financial burden was the primary barrier to adherence, with nearly 28% reporting cost-related nonadherence, particularly among lower socioeconomic status (SES) patients. Social stigma influenced adherence, especially in urban areas (19.8% reported stigma). Positive beliefs about medications correlated with better adherence. A confirmed COPD and asthma diagnosis and using specific inhaler devices (dry powder inhaler, PMDI with spacer) were linked to improved adherence.

CONCLUSION: Significant factors impacting medication adherence in COPD include financial constraints, social stigma, medication beliefs, and inhaler device type. Addressing these through cost-reduction strategies, stigma interventions, and educational programs can improve COPD management and outcomes, especially for older adults and lower SES populations.

Share

COinS